Global Bivalirudin Drug Market Growth Fueled by Expanding Cardiac Catheterization Volumes
The Bivalirudin Drug Market is expanding as healthcare providers increasingly use direct thrombin inhibitors for anticoagulation in patients undergoing percutaneous coronary intervention (PCI) and other cardiovascular procedures. Market Overview The global Bivalirudin Drug market was valued at US$ 1.58 billion in 2025 and is expected to reach US$ 2.72 billion by 2034; it is estimated to record...
0 Comments 0 Shares 11 Views 0 Reviews